All In MedTech

Company

Coloplast A S

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

From SEC filings.

We found no SEC financing filings under the name Coloplast A S, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

No 5%+ shareholder filings or SBIR grants found under the name Coloplast A S.

Latest FDA decisions

The 8 newest of 9 since 2015.

Search the Clearance Tracker

8 more FDA decisions with a free account

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar
  • INTIBIA Pivotal StudyPivotal-lookingActive, not recruiting

    NCT05250908 · 208 participants · Start Mar 7, 2022 · Primary completion May 12, 2025

    Device: INTIBIA Therapeutic; INTIBIA Non-Therapeutic · For: Urinary Incontinence, Urge; Urinary Bladder, Overactive; Urinary Bladder Diseases and 3 more

    Sites: Beverly Hills, California; Los Angeles, California; Washington D.C., District of Columbia · 22 sites in all

113 more trials with a free account

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 237711200
Jan 244814300
Feb 244214600
Mar 245712800
Apr 244115600
May 245913110
Jun 245110900
Jul 246417200
Aug 245815100
Sep 245217710
Oct 245022600
Nov 244319600
Dec 245216410
Jan 253513200
Feb 253917620
Mar 254314400
Apr 255619100
May 253515100
Jun 253612900
Jul 254215300
Aug 2513613400
Sep 2521016900
Oct 255014400
Nov 254211600
Dec 255313400
Jan 266413800
Feb 267413100
Mar 265613700
Apr 267619500
May 264613500
Jun 267126400
Jul 264216500
Aug 264315000
Sep 266613600
Oct 266513600
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

7 more in this ranking with a free account

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

7 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

No recalls under this name in FDA's data.

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.